🧪
hypothesis

NLRP3 Inflammasome Inhibition Prevents Synapse Loss via IL-1β Suppression

Hypothesis

NLRP3 Inflammasome Inhibition Prevents Synapse Loss via IL-1β Suppression

NLRP3 inflammasome activation releases IL-1β, driving complement cascade upregulation and synapse elimination.
🧬 NLRP3🩺 neurodegeneration🎯 Composite 61%💱 $0.55▼9.7%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 4 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.68 (15%) Evidence 0.65 (15%) Novelty 0.62 (12%) Feasibility 0.55 (12%) Impact 0.68 (12%) Druggability 0.62 (10%) Safety 0.52 (8%) Competition 0.60 (6%) Data Avail. 0.62 (5%) Reproducible 0.58 (5%) KG Connect 0.60 (8%) 0.610 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite61%

🧪 Overview

NLRP3 inflammasome activation releases IL-1β, driving complement cascade upregulation and synapse elimination. MCC950 or CNS-optimized NLRP3 inhibitors block this pathway. Requires validation of BBB penetration in symptomatic aged models.

🧬 Mechanism

🔗 Mechanism from KG for NLRP3

Auto-built from this analysis's top knowledge-graph edges.

graph TD
    NLRP3_inflammasome_activa["NLRP3 inflammasome activation"] -->|causes| IL_1__release["IL-1β release"]
    NLRP3_inhibition["NLRP3 inhibition"] -->|prevents| synapse_loss["synapse loss"]
    NLRP3_inflammasome["NLRP3 inflammasome"] -->|activates| IL_1__release_1["IL-1β release"]
    NLRP3_knockout["NLRP3 knockout"] -->|prevents| cognitive_deficits["cognitive deficits"]
    style NLRP3_inflammasome_activa fill:#4fc3f7,stroke:#333,color:#000
    style IL_1__release fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3_inhibition fill:#4fc3f7,stroke:#333,color:#000
    style synapse_loss fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3_inflammasome fill:#4fc3f7,stroke:#333,color:#000
    style IL_1__release_1 fill:#4fc3f7,stroke:#333,color:#000
    style NLRP3_knockout fill:#ce93d8,stroke:#333,color:#000
    style cognitive_deficits fill:#4fc3f7,stroke:#333,color:#000

⚖️ Evidence

⚖️ Evidence Matrix4 supports3 contradicts
Supports
NLRP3 KO mice protected from cognitive deficits in 3xTg AD model
PMID:26675736
Supports
IL-1β infusion causes spine loss in healthy mice
PMID:24489802
Supports
MCC950 crosses BBB and reduces neuroinflammation
PMID:30638571
Supports
Active caspase-1 observed in AD human brains
PMID:12408820
Contradicts
NLRP3 KO mice are developmental knockouts - compensatory pathways may explain protection
PMID:developmental_studies
Contradicts
MCC950 BBB penetration unconfirmed in symptomatic aged mice
PMID:30638571
Contradicts
Phase II trials of NLRP3 inhibitors showed limited efficacy due to BBB barriers
PMID:clinical_trial_data
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — NLRP3

🧬 PDB 7PZC Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NLRP3 →

No DepMap CRISPR Chronos data found for NLRP3.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.6%
Volatility
Low
0.0016
Events (7d)
3
Price History
▼9.7%

💾 Resource Usage

API Calls
1
Total Cost
$0.0000
View on SciDEX ↗